Sio Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-387,751
Closed -$3.5M 89
2025
Q4
$3.5M Sell
387,751
-441,427
-53% -$3.3M 0.55% 39
2025
Q3
$2.58M Sell
829,178
-478,786
-37% -$1.27M 0.65% 35
2025
Q2
$2.8M Sell
1,307,964
-1,274,691
-49% -$2.06M 1.07% 25
2025
Q1
$2.97M Sell
2,582,655
-1,464,142
-36% -$2.51M 0.88% 28
2024
Q4
$8.86M Buy
4,046,797
+2,074,849
+105% +$4.7M 2.49% 13
2024
Q3
$4.3M Buy
1,971,948
+1,193,024
+153% +$2.74M 1.7% 19
2024
Q2
$1.8M Buy
778,924
+400,924
+106% +$1.67M 0.49% 32
2024
Q1
$2.08M Buy
+378,000
New +$1.73M 0.62% 36

Other funds holding VTYX

Sio Capital Management's VTYX Position: Q1 2026 in Review

Sio Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 387,751 shares — an estimated $3.5M sold.

Sio Capital Management first reported a position in VTYX in Q1 2024 and held it in 8 quarters. The position peaked at $8.86M in Q4 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Sio Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Sio Capital Management sold 387,751 Ventyx Biosciences shares in Q1 2026, an estimated $3.5M.
  • Sio Capital Management first reported a position in Ventyx Biosciences in Q1 2024 and held it in 8 quarters.
  • Sio Capital Management's Ventyx Biosciences position peaked at $8.86M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.